
Jason Hinman
@hinmanlabucla
Translational Neuroscience Lab focused on cerebral microvascular disease and white matter damage and repair
ID: 2416987908
http://www.hinmanlabucla.org 29-03-2014 05:28:20
870 Tweet
732 Followers
514 Following



There are now two FDA-approved treatments for the early stages of Alzheimerās disease, Lecanemab & Donanemab. Dr. Leila Parand, a Neurology & Neurobehavioral Specialist at David Geffen School of Medicine at UCLA UCLA Easton Center for Alzheimer's Research & Care, reviews the cost and available insurance coverage options. youtu.be/5o-HZNwQrQs?siā¦

This is great work Mitch Guttman which I recently had the privilege of learning about from #isabel UCLA Neurology event. Looking forward to putting this technique to work in #stroke


Published today: Vascular Neurology Considerations for Antiamyloid Immunotherapy āš¼Hugo J. Aparicio, MD, MPH, FAHA Jason Hinman Mariel Kozberg Steven M. Greenberg MD, PhD Manu Goyal š· Example of symptomatic amyloid-related imaging abnormalities in the form of vasogenic edema.


This week the UCLA Easton Center for Alzheimer's Research & Care, Alzheimer's Los Angeles, and the Sam and Ida Turken Charitable Foundation awarded Dr. Chao Peng the 2024 Turken Research Award. Samar Padder (Drug Discovery Lab) and Chloe Sy Perez (Chang Lab) received awards for their abstracts.


We are proud to announce that Samar Padder, SRA of the Drug Discovery Lab, and Chloe Sy Perez, undergraduate student of the Chang Lab UCLA Neurology, were among 24 outstanding abstract applicants selected to present at the 2024 Turken Research event. Congratulations!


The Easton Center of UCLA Neurology, UCLA Samueli Engineering, #UCLAPharmacology, UCLA Bioengineering, UCLA CS Department, and other members of the David Geffen School of Medicine at UCLA joined forces today to discuss the next innovative approach to using digital solutions for people with #Alzheimerās and #dementia.


Today Jason Hinman will present at AHA Science International Stroke Conference 2025. His talk will be featured at the āBench to Bedside and Beyond -Understanding Sporadic CSVD Through the Lens of CADASIL And Other Monogenic CSVDSā symposium session. #ISC25


š„Carotid webs, presented by Shadi Yaghi ā¶ļø~3% of ESUS cases; 10% of anterior circle cryptogenic strokes ā¶ļøMechanism is usually stagnant flow causing thrombus formation, artery to artery embolism ā¶ļøHigh-risk mechanism (MR CLEAN data shows inc risk of ischemic stroke (about 1/7)

Members of the Brain-health Education and Advocacy Movement (BEAM), an undergraduate student club affiliated with UCLA Easton Center for Alzheimer's Research & Care, spoke with Dr. Dan Silverman of UCLA Molecular & Medical Pharmacology to discuss the importance of NeuroPET scans to assess neurodegenerative diseases.



We are thrilled to introduce the UCLA Neurology Residency Class of 2029! Please join us in congratulating and welcoming our newest residents! #MatchDay2025 UCLA Health David Geffen School of Medicine at UCLA UCLA


Help support Alzheimerās care and research in California. Take a moment to reach out to legislators and make a difference for families affected by #Alzheimerās. Itās quick and easy! alz-ca.quorum.us/campaign/11598⦠UCLA Health UCLA Neurology Alzheimer's Association Alzheimer's Association California Southland



A sincere thank you to Dr. Tirth Patel of UCLA Neurology UCLA Health for presenting at the recent Brain-Health Education and Advocacy Movement (BEAM) meeting! Club members gained invaluable insights into #dementia and #Alzheimers, from cutting-edge diagnosis to treatment options.


On May 15th, the Annual Faith & Health Luncheon was co-sponsored by West Angeles Church, @alzheimersla, and UCLA Easton Center for Alzheimer's Research & Care. Over 300 members of local Black churches gathered to learn about #dementia caregiving, with a focus on wandering/ getting lost. UCLA Neurology UCLA Health
